Bristol-Myers Squibb Co
(LTS:0R1F)
$
59.4
-0.61 (-1.02%)
Market Cap: 119.70 Bil
Enterprise Value: 163.01 Bil
PE Ratio: 0
PB Ratio: 6.98
GF Score: 82/100 
Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 03:40PM GMT
Release Date Price:
$68.1
(+1.57%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the first morning of the BofA Healthcare Conference. My name is Geoff Meacham. I'm a senior biopharma analyst, and we are excited to have Bristol-Myers here. And Adam Lenkowsky is here, who recently was promoted to EVP, Head of Commercial. So congratulations.
Adam Lenkowsky
Bristol-Myers Squibb Company - Executive VP, Chief Commercialization Officer & Head of U.S. Oncology
Thank you, Geoff. Great to be here.
Questions & Answers
Geoffrey Christopher Meacham;Adam Lenkowsky
BofA Securities, Research Division - Research Analyst;Bristol-Myers Squibb Company - Executive
Let's just kick off with that. Like so give us -- as you evolve into the new role, you already know a lot of the commercial business around the world and different therapeutic areas. Give us kind of your -- what would be your top 3 kind of list of priorities as you look to the back half of this year and into next?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers